Trial
NCT02284425
Study of REGN1193 in Patients With Type 2 Diabetes Mellitus
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Regeneron Pharmaceuticals
Collaborators
—
Condition
Diabetes Mellitus, Type 2
Intervention
REGN1193
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-05-12